• Reset filters

consultation
Publications Nov 08, 2022

New unfair contract term laws in Australia introduce large financial penalties

Significant changes to the unfair contract term provisions in the Australian Consumer Law, including potential financial penalties, will soon apply.

News Dec 05, 2022

Sean Kelley to present at World Renewable Energy Congress in Perth

Sean Kelley will join the speaker line-up at the 2022 World Renewable Energy Congress, hosted by Murdoch University in Perth from 4-9 December.

binary code
Publications Nov 18, 2022

Full Court correct in deciding that only humans can invent

High Court confirms that an artificial intelligence system can not be named as an inventor of a patent.

News Nov 11, 2022

Griffith Hack’s Edith Hamilton joins speaker line-up at IPBC Australasia 2022

Griffith Hack will have a strong presence at IPBC Australasia 2022 with special counsel Edith Hamilton joining the event’s line-up of speakers.

biotech
Publications Nov 09, 2022

Are you patent ready? IP guidance for life sciences researchers

Whether you are an academic or industry-based researcher, the question is the same: when is the right time to file a patent application?

technology products
Publications Nov 01, 2022

Making your mark: Protect your product with patent marking 

We explore the concept of patent marking, the real meaning of patent pending, and when you as an inventor or product owner should mark your product.

cells
News Sep 26, 2022

Griffith Hack sponsors Fragment-Based Drug Discovery Down Under Conference 2022

Griffith Hack is proud to sponsor the 2022 edition of the Fragment-Based Drug Discovery Down Under Conference.

Publications Aug 18, 2022

Soft decision on computer-implemented inventions

Dr Simone Shu-Yen Lee and Tom Hamilton-Gilligan provide early insights into the High Court’s decision of Aristocrat Technologies Australia Pty Limited v Commissioner of Patents [2020] FCA 778 (5 June 2020).

Insights Aug 10, 2022

Karen Sinclair talks synthetic biology on the From Idea to Intellectual Property podcast

Karen Sinclair joins host Lisa Leong on the From Idea to Intellectual Property podcast series to discuss the emerging trends and key issues in the area of synthetic biology.

car lights
Insights Jul 01, 2022

Griffith Hack announces the promotion of five team members

Griffith Hack is proud to announce the promotion of five members of our team, including the elevation of Jennifer Wyndham-Wheeler to principal.

Publications Jun 01, 2022

Spotlight Series: Regenerative Medicine – Part 2

Welcome to the second article of our Spotlight Series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.

placeholder
News May 10, 2022

Amanda Stark, Janelle Borham named Patent Stars for 2022 by Managing IP

Griffith Hack principals Amanda Stark and Janelle Borham have been named as Patent Stars in the IP STARS 2022 rankings by Managing IP.

microchip
Publications Apr 13, 2022

Reversal of fortune – Full Court decides that an artificial intelligence is not an “inventor”

Anthony Selleck reviews the decision in Commissioner of Patents v Thaler [2022] FCAFC 62 which reverses an earlier ruling that artificial intelligence can be an “inventor” for the purposes of the Australian Patents Act 1990.

patents
Publications Apr 08, 2022

AI and Digital Capability Centre Grants: What you need to know before applying

Applications are now open for Artificial Intelligence (AI) and Digital Capability Centre Grants of up to $11 million. Here’s what you need to know before applying.

advanced manufacturing
Publications Mar 30, 2022

Federal Budget 2022: What’s in it to accelerate Australia’s innovation agenda?

We discuss the key measures in Australia’s 2022-23 federal budget that could help drive innovation, research commercialisation and business growth.

Publications Mar 07, 2022

From idea to inception and beyond: Important learnings from female biotech founders

Female biotech founders took centre-stage at AusBiotech 2021 with the leaders of some of Australia’s most innovative start-ups coming together to discuss their experiences in the commercial scientific world.

research team
Publications Mar 04, 2022

Saving grace: Options if you disclose your invention without a patent application 

Publicly disclosing new technology before a patent application has been filed can jeopardise patent coverage – but there are options available to you in the event of disclosure.

cells
Publications Mar 02, 2022

Virus filtration patent gets clean bill of health

In a recent decision of the Australian Patent Office, a patent application directed to a membrane for filtering biological products was upheld following opposition.

News Feb 18, 2022

Jacqui Thomas, Daniel Hsieh register as patent attorneys in Australia and New Zealand

Griffith Hack is pleased to announce that Jacqui Thomas and Daniel Hsieh are now registered patent attorneys in Australia and New Zealand.

pharma
Publications Feb 10, 2022

Awkward first dates:
How is patent term extension calculated when a patent covers more than one pharmaceutical substance with regulatory approval?

Bayer Pharma Aktiengesellschaft [2022] APO

tablets
Publications Jan 28, 2022

Extending the 12-month grace period for filing patent applications – what you need to know

Can the 12-month grace period for filing your patent application be extended? Yes, it can – but subject to the facts.

Ben Dziekan
News Dec 22, 2021

Ben Dziekan wins IPTA’s prestigious Edward Waters Prize for 2021

Melbourne-based patent attorney Ben Dziekan has been named co-winner of the Institute of Patent and Trade Mark Attorneys of Australia’s prestigious Edwards Waters Prize for 2021.

consultation
Publications Nov 19, 2021

Your Australian patent application has been opposed – what next?

Australia’s pre‑grant opposition proceedings are playing a more significant role in the strategies of patentees and challengers. So what should a patent owner do when faced with an opposition in Australia?

biotech
Publications Oct 27, 2021

Why are embryonic stem cells not able to be patented in Australia?

Despite not being specifically excluded under s18 of the Australian Patents Act, technology utilising embryonic stem cells is not able to be patented in Australia. Why is this so?

mushroom-research
Publications Oct 22, 2021

Recent progress in psychedelic therapies

With increasing awareness of the prevalence of mental ill-health in society, we analyse promising psychedelic therapies that have not yet entered mainstream.

chemistry
Publications Oct 20, 2021

Spotlight Series: Regenerative Medicine – Part 1

The first in a five-part series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.

wind energy engineer
Publications Oct 15, 2021

Innovation patents: options for challenging problematic cases

What are your options if you identify an innovation patent that affects your freedom to operate?

gavel
Publications Aug 26, 2021

Patent drafting conventions fall foul of Australian Courts

In a recent opposition appeal decision of the Federal Court of Australia, an Australian patent application by Nalco Company was found invalid for lack of support and lack of clear enough and complete enough disclosure.

Vaccines
Publications Aug 20, 2021

Revisiting how early is earliest? Further developments in Australian patent term extension law

Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2021] FCA 947

polymers
Publications Aug 18, 2021

Expert evidence keeps RAFT buoyant in strawman patent opposition

Commonwealth Scientific and Industrial Research Organisation (CSIRO) v Cytec Industries Inc. [2021] APO 27

law gavel
Publications Aug 05, 2021

A comeback for Australian patent oppositions

With Australia’s innovation patent system set to end later this month, pre-grant opposition proceedings will likely play a significant role in the strategies of challengers.

research
Publications Aug 04, 2021

Draft roadmap for Australian regenerative medicine released for comment

AusBiotech has released a draft strategic roadmap for a new regenerative medicine Catalyst.

dna research
Publications Jul 02, 2021

Guidance on patenting diagnostics in Australia: Ariosa Diagnostics v Sequenom

Federal Court confirms that a non-invasive diagnostic test for prenatal conditions is patentable subject matter in Australia.

researcher in lab
Publications Jun 18, 2021

How the proposed patent box scheme could benefit Australian industry

Principal Karen Sinclair discusses the Australian Government’s proposed patent box scheme and what needs to be considered to ensure successful implementation.

News Jun 17, 2021

Griffith Hack maintains top tier status in IP STARS 2021 rankings

Griffith Hack has maintained its status as an industry leader in patent prosecution, receiving tier one status in the IP Stars 2021 rankings. Principals Janelle Borham and Amanda Stark were both recognised individually as Patent Stars.

lab research
Publications Jun 16, 2021

How early is earliest? Developments in Australian patent term extension law

Malcolm Lyons looks at the decision in Ono Pharmaceutical Co, Ltd v Commissioner of Patents which has provided long needed clarity on requests for patent term extension.

solar farm
Publications May 26, 2021

The end is near for Australia’s innovation patent system: What you need to know

Australia’s innovation patent system is ending soon, but, there’s still time to take advantage of the system – you just need to act soon.

growth
Publications May 12, 2021

Australia’s Federal Budget 2021: Key takeaways and opportunities

Investment in tech, research and innovation highlights value of IP protection

engineers consulting
Publications Dec 07, 2020

Australian government rediscovers R&D value amid COVID-19 crisis

With two quarters of consecutive GDP contraction due to coronavirus-related shutdowns, Australia is now poised to face economic challenges not experienced since 1991.

researcher in lab
Publications Dec 01, 2020

Thirteen – unlucky for some: Support and sufficiency in Australia following MSD v Wyeth

The MSD v Wyeth judgment demonstrates the more exacting standard now required for the level of disclosure in patent specifications. It also cements the shift in Australia towards alignment with UK and European requirements.

research
Publications Nov 18, 2020

Ono: Broader is not always better

Why is patent term extension is so important to companies developing and commercialising new pharmaceutical substances?

website
Publications Oct 20, 2020

Protecting your digital health

Track and trace smartphone applications used in the fight against COVID 19 are representative of a relatively new industry falling between the healthcare, IT, medical devices and pharmaceutical sector. 

Covid-19
Publications Oct 19, 2020

Owning COVID-19: Would if you could?

f the Earth’s biome, viruses are part of its biodiversity, but has consideration been given as to whether anyone can ‘own’ or should benefit from COVID-19? 

chemistry
Publications Aug 17, 2020

Unproven hypotheses in clinical trials can be novelty-destroying

We review the decision in Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd which may have far-reaching implications for pharmaceutical patent holders or applicants in Australia.

tablets
Publications Jun 18, 2020

Pharmacoeconomics and patent practice in Australia

While Australia remains an attractive destination for patentees, a careful patent strategy is required to negotiate its complex regulatory, demographic and socioeconomic environment.

News Feb 07, 2020

Griffith Hack announces the elevation of two team members to principal

Griffith Hack is thrilled to formally announce the elevation of Gavin Adkins and Robyn Heard to principal.

Publications Mar 04, 2019

Simple steps to better IP portfolio management

Continuous portfolio management is a crucial plank of best practice intellectual asset management.

cells
Publications Jul 17, 2018

CRISPR-Cas9 Update: Collision of Trends in IP and Life Sciences

CRISPR-Cas9 genome editing may not just be the greatest scientific breakthrough of this century, but also provides many lessons on patenting life science technologies.